Masimo Cash Flow Statement
MASI / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 15 fiscal years. All figures from audited SEC 10-K filings.
Masimo generated $218M in operating cash flow and $198M in free cash flow in FY2025. Free cash flow margin was 13.0% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Negative profit margin: -14.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$151.5M | -$304.9M | $81.5M | $143.5M | $229.6M | $64.5M | $49.3M | $311.1M | $124.8M | $72.5M | $58.4M | $62.3M | $63.7M | $62.3M | $53.2M |
| Depreciation & Amortization | $38.8M | $48.5M | $38.9M | $136.1M | $35.6M | $29.3M | $20.1M | $16.8M | $20.1M | $12.8M | $11.4M | $9.4M | $7.3M | $9.4M | $6.0M |
| Operating Cash Flow | $217.8M | $196.4M | $94.1M | $29.4M | $264.6M | $211.1M | $56.1M | $419.1M | $56.1M | $95.6M | $55.1M | $75.1M | $79.0M | $75.1M | $47.1M |
| Capital Expenditures | $19.4M | $21.1M | $38.4M | $52.8M | $25.5M | $72.5M | $43.7M | $19.7M | $43.7M | $75.1M | $9.4M | $10.5M | $5.1M | $10.5M | $3.6M |
| Free Cash Flow | $198.4M | $175.3M | $55.7M | -$23.4M | $239.1M | $138.6M | $12.4M | $399.4M | $12.4M | $20.6M | $45.7M | $64.6M | $73.9M | $64.6M | $43.5M |
| Share Buybacks | $363.7M | $0 | $0 | $401.5M | $128.9M | $110.5M | $66.3M | $68.2M | $66.3M | $102.5M | $19.8M | $26.3M | $36.2M | $26.3M | $36.2M |
| Dividends Paid | - | - | - | - | - | - | - | - | - | - | - | $57.3M | $0 | $57.3M | $162.0M |
| FCF Margin | 13.0% | 12.6% | 4.4% | -1.1% | 80.0% | 12.1% | 1.6% | 56.0% | 1.6% | 3.5% | 8.3% | 13.1% | 16.8% | 13.1% | 12.4% |